种族与族裔视角下的瓣膜性心脏病:JACC 焦点研讨 4/9
本文为 JACC 焦点研讨文章,综述种族、族裔与医疗差异背景下瓣膜性心脏病的病因、诊断与治疗差别。文中指出,全球部分地区仍承受未治疗风湿性心脏病后果,中高收入国家因人口老龄化致钙化性主动脉瓣与二尖瓣病患病率上升,感染性心内膜炎高发加重负担;尽管社会经济与医学危险因素、诊断可及性和适当治疗提供方面存在显著医疗差异,种族与族裔因素尚未在瓣膜性心脏病研究中占据中心地位。
要点
- 瓣膜性心脏病是全球重大公共卫生问题,风湿性、钙化性与感染性病因负担并存。
- 中高收入国家钙化性主动脉瓣与二尖瓣病患病率上升,部分归因于人口老龄化。
- 社会经济与医学危险因素、诊断可及性和治疗提供存在显著医疗差异。
核心结论
- 种族与族裔及医疗差异尚未在瓣膜性心脏病研究中占据中心地位,尽管已有证据显示诊疗各环节存在显著差异。
研究设计与样本
- 本文为 JACC 焦点研讨综述,回顾种族、族裔与医疗差异背景下瓣膜性心脏病的病因、诊断和治疗差异。
主要发现
- 世界许多地区仍在应对未治疗风湿性心脏病的不良后果,该病通过及时获得诊断和治疗在很大程度上可预防。
- 中高收入国家钙化性主动脉瓣与二尖瓣病患病率上升,部分归因于人口老龄化。
- 感染性心内膜炎高发且与显著发病率和死亡率相关,进一步加重瓣膜性心脏病的公共卫生负担。
- 社会经济与医学危险因素、诊断可及性及适当治疗提供方面存在显著医疗差异。
临床怎么用
- 临床应关注瓣膜性心脏病患者在危险因素、诊断可及性与治疗提供方面的种族与族裔相关差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Valvular heart disease (VHD) is a major global public health problem. Many regions of the world continue to grapple with the adverse consequences of untreated rheumatic heart disease, a condition that is largely preventable with timely access to diagnosis and treatment. In turn, middle- and high-income countries have experienced a rise in the prevalence of calcific aortic and mitral disease, owing in part to population aging. This public health problem is further compounded by high rates of infective endocarditis, which is associated with substantial morbidity and mortality. Yet, considerations of race and ethnicity have not taken center stage in VHD research. This is despite evidence of major health care disparities in socioeconomic and medical risk factors, access to diagnosis, and provision of appropriate treatment. In this paper, the authors review differences in the etiology, diagnosis, and treatment of VHD within the context of race, ethnicity, and health care disparities.
引用
- Lamprea-Montealegre JA, Oyetunji S, Bagur R, et al. Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9. J Am Coll Cardiol. 2021. PMID: 34886971. doi:10.1016/j.jacc.2021.04.109
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。